Free Trial
OTCMKTS:ORINY

Orion OYJ Q1 2025 Earnings Results & Report

Orion OYJ logo
$57.89 0.00 (0.00%)
As of 11/12/2026 02:59 PM Eastern

Orion OYJ reported Q1 2025 earnings on April 23, 2025. The company reported EPS of $0.23, while revenue was $373.03 million.

Earnings Announcement Details

Quarter
Q1 2025
Report Date
Time
Before Market Opens

Orion OYJ EPS Results

Actual EPS
$0.23
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Orion OYJ Revenue Results

Actual Revenue
$373.03 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Orion OYJ Q1 2025 Earnings FAQ

Orion OYJ (OTCMKTS:ORINY) reported earnings of $0.23 per share for Q1 2025. The report was announced on Wednesday, April 23, 2025.

Orion OYJ reported revenue of $373.03 million for Q1 2025.

Orion OYJ Earnings Headlines

Orion Oyj
URGENT: If you own a home, please review the map below.
More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards urges homeowners to check the map and see whether one is near them. Families in Georgia have been forced to sell, entire Ohio neighborhoods are being torn down, and nearly 50,000 Lake Tahoe residents face losing power. Rickards advised the Pentagon and the U.S. intelligence community for decades. He says one man outside Washington can stop it.tc pixel
See More Orion OYJ Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Orion OYJ? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Orion OYJ and other key companies, straight to your email.

About Orion OYJ

Orion OYJ (OTCMKTS:ORINY) is a Finnish pharmaceutical company that develops, manufactures and markets medicines for human and veterinary use. Its portfolio includes prescription and over-the-counter medicines, as well as active pharmaceutical ingredients supplied to other pharmaceutical companies.

Founded in 1917 and headquartered in Espoo, Finland, Orion has a long history in the pharmaceutical industry. The company focuses on areas including oncology, neurology and respiratory diseases, and develops some products in collaboration with international pharmaceutical partners.

Orion serves customers in Finland and other European markets, while partnerships and product sales extend its reach to markets around the world. Its operations also include research and development, manufacturing and the commercialization of medicines.

View Orion OYJ Profile